JOHNSON PHARMACARE LIMITED (JOHNPHARMA.BO)
INR 1.19
(-0.84%)
INR 1.19
(-0.84%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -454 Thousand | -115.84 Million | 48.96 Million | -1.08 Million | 1.68 Million | -9.3 Million |
| Net Income | -1.96 Million | -12.91 Million | 966.56 Thousand | 11.74 Thousand | -918.05 Thousand | -109.35 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.5 Million | -102.93 Million | 47.99 Million | -1.1 Million | 2.6 Million | -9.2 Million |
| Other non-cash items | - | -10.5 Million | 200 Thousand | 1.1 Million | -2.6 Million | 9.2 Million |
| Investing Cash Flow | - | 102.45 Million | -50.05 Million | - | 8.75 Million | 9 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -19.2 Million | - | - | - |
| Sales/Maturities of investments | - | 86.2 Million | - | - | 8.75 Million | 9 Million |
| Other Investing Activities | - | 16.25 Million | -30.85 Million | - | - | - |
| Financing Cash Flow | 450 Thousand | 13 Million | -829.93 Thousand | 622.43 Thousand | -10.68 Million | 100.00 |
| Debt repayment | -450 Thousand | -13 Million | -829.93 Thousand | -622.43 Thousand | -10.68 Million | -100.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | 25.00 | 200.00 |
| Accounts receivables | - | 10.5 Million | 6.3 Million | -7.6 Million | 2.6 Million | -9.2 Million |
| Accounts payables | - | - | -6.5 Million | 6.5 Million | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.5 Million | -113.43 Million | 48.19 Million | - | - | - |
| Cash at beginning of period | 18 Thousand | 405.67 Thousand | 2.32 Million | 2.78 Million | 3.04 Million | 3.34 Million |
| Cash at end of period | 14 Thousand | 18 Thousand | 405.67 Thousand | 2.32 Million | 2.78 Million | 3.04 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | 326.00 | - | - | - | - |
| Net cash flow / Change in cash | -4000.00 | -387.67 Thousand | -1.92 Million | -461.7 Thousand | -252.02 Thousand | -309.25 Thousand |
| Free Cash Flow | -454 Thousand | -115.84 Million | 48.96 Million | -1.08 Million | 1.68 Million | -9.3 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.96 Million | -46 Thousand | -18 Thousand | -1.87 Million | -12.91 Million | -837 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.5 Million | - | - | - | -102.93 Million | - |
| Other non-cash items | - | 46 Thousand | 18 Thousand | 1.87 Million | -10.5 Million | 837 Thousand |
| Investing Cash Flow | - | - | - | - | 102.45 Million | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 86.2 Million | - |
| Other Investing Activities | - | - | - | - | 16.25 Million | - |
| Financing Cash Flow | 450 Thousand | - | - | - | 13 Million | - |
| Debt repayment | -450 Thousand | - | - | - | -13 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | 10.5 Million | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.5 Million | - | - | - | -113.43 Million | - |
| Cash at beginning of period | 18 Thousand | 19 Thousand | 37 Thousand | 18 Thousand | 405.67 Thousand | 855 Thousand |
| Cash at end of period | 14 Thousand | -46 Thousand | 19 Thousand | -1.87 Million | 18 Thousand | 18 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | 326.00 | - |
| Net cash flow / Change in cash | -4000.00 | -65 Thousand | -18 Thousand | -1.89 Million | -387.67 Thousand | -837 Thousand |
| Free Cash Flow | -454 Thousand | -46 Thousand | -18 Thousand | -1.87 Million | -115.84 Million | -837 Thousand |
GML
2125
1NBA
MAHAPEXLTD
DRMA
6349